Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Petadeferitrin relative bioavailability and pharmacokinetics study in healthy volunteers
NL-OMON61034Phase 1Suspended
- Sponsor
- Pharmacosmos
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of petadeferitrin in iron overload (2 arms), sponsored by Pharmacosmos. Started Apr 2026; status: suspended.
02
Drugs
petadeferitrin
03
Conditions
iron overload
Beyond the preview
Go deeper on NL-OMON61034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61034.